Cidara Therapeutics, Inc. (DELISTED) (CDTX:DL)
221.38
0.00 (0.00%)
USD |
NASDAQ |
Feb 25, 16:00
Cidara Therapeutics Cash from Investing (Quarterly) : -176.47M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co., Inc. | -11.20B |
| Cogent Biosciences, Inc. | -322.77M |
| Olema Pharmaceuticals, Inc. | 17.27M |
| Rhythm Pharmaceuticals, Inc. | 30.35M |
| BridgeBio Pharma, Inc. | -13.75M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -40.62M |
| Cash from Financing (Quarterly) | 0.16M |
| Free Cash Flow | -132.94M |
| Free Cash Flow Per Share (Quarterly) | -1.511 |
| Free Cash Flow to Equity (Quarterly) | -40.27M |
| Free Cash Flow to Firm (Quarterly) | -40.62M |
| Free Cash Flow Yield | -3.62% |